Managers / Q1 2024
Endurant Capital Management LP
CIK 0001633055 · 66 BOVET ROAD, SUITE 353, SAN MATEO, CA, 94402 · 650-539-5905
Reported Value
$0
Q1 2024
Positions
1
Filings on Record
24
2019–present window
Filed
May 7, 2024
original filing
Summary
Compared with Q4 2023, the fund opened 1 new position and exited 25.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
vs Q4 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| Nothing to Declare | NEW | +0 | 0 | +$0 | $0 |
| BSXBOSTON SCIENTIFIC CORP | SOLD OUT | −39.1K | 0 | −$2M | $0 |
| TMOTHERMO FISHER SCIENTIFIC INC | SOLD OUT | −3.8K | 0 | −$2M | $0 |
| AXNX*AXONICS INC | SOLD OUT | −24.9K | 0 | −$2M | $0 |
| ELVELEVANCE HEALTH INC | SOLD OUT | −2.6K | 0 | −$1M | $0 |
| ICON PLC | SOLD OUT | −3.7K | 0 | −$1M | $0 |
| LABORATORY CORP AMER HLDGS | SOLD OUT | −4.0K | 0 | −$905,523 | $0 |
| EHCENCOMPASS HEALTH CORP | SOLD OUT | −12.9K | 0 | −$858,686 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2024 | $0 | 1 | May 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $17M | 25 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $111M | 43 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $115M | 34 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $195M | 50 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $246M | 55 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $307M | 49 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $285M | 50 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $380M | 63 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $414M | 68 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $439M | 53 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $364M | 57 | Aug 27, 2021 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2021 | $384M | 61 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $277M | 52 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $338M | 60 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.8B | 56 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $221M | 51 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $317M | 54 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $279M | 49 | Nov 25, 2019 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2019 | $254M | 50 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $253M | 70 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $189M | 48 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.